Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 9—September 2007

Research

Simian Foamy Virus Transmission from Apes to Humans, Rural Cameroon

Sara Calattini*, Edouard B.A. Betsem†, Alain Froment‡, Philippe Mauclère*†‡§, Patricia Tortevoye*, Christine Schmitt*, Richard Njouom§, Ali Saib¶, and Antoine Gessain*Comments to Author 
Author affiliations: *Institut Pasteur, Paris, France; †Université de Yaoundé I, Yaoundé, Cameroun; ‡Centre de l'InstitutdeRecherchepourleDéveloppement, Orléans, France; §Centre Pasteur du Cameroun, Yaoundé, Cameroun; ¶Hôpital Saint Louis, Paris, France;

Main Article

Figure 2

A) Western blot (WB) results based on chimpanzee (cpz) simian foamy virus (SFV) antigens. B) WB results based on monkey simian foamy virus antigens originating from participant AG16. C) Example of sero-indeterminate samples (lanes 1–7) and negative samples (lanes 8–13), detected by cpzSFV WB. Last lane (POS cpz), serum from an SFV-positive chimpanzee.

Figure 2. A) Western blot (WB) results based on chimpanzee (cpz) simian foamy virus (SFV) antigens. B) WB results based on monkey simian foamy virus antigens originating from participant AG16. C) Example of sero-indeterminate samples (lanes 1–7) and negative samples (lanes 8–13), detected by cpzSFV WB. Last lane (POS cpz), serum from an SFV-positive chimpanzee.

Main Article

TOP